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Abstract 
It has been 50 years since the first histone methylation was identified. From then, numerous 
studies have verified that histone methylation neutralizes the positive charges of lysine, alters 
chromatin architectures, and recruits other DNA binding complexes. In this study, we 
examined the molecular basis of a histone demethylase – KDM5B in both its substrate and 
binding machineries. We hypothesized that KDM5B has alternative binding partners and 
substrates besides its known target H3K4me3. By utilizing biochemical approaches such as 
in vitro pull-down assays and fluorescence polarization assays, we were able to identify 
potential KDM5B binding partners – H2BK43me0/2.  Also, we reinvestigated the 
recognition mechanisms and found that the unmodified H2BK43me0 was a potential binding 
site of PHD1 and PHD2 while H2BK43me2 was a potential partner of PHD1. In addition, we 
observed H2BK43me2 demethylation via KDM5B in MCF7 cells. Together, our preliminary 
results suggested that H2BK43me2 was an alternative binding partner and substrate of 
KDM5B. 
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Chapter 1  
 Literature review 
 
1.1 DNA, histone and chromatin 
In the eukaryotic genome, DNA is the basic molecule used to encrypt genetic information. 
DNA is a polymer of nucleotides, which consists of pentose sugars, nitrogenous bases 
and phosphate groups. From 1885 to 1901, Albrecht Kossel and his colleagues 
discovered nucleic acids contain five nitrogen-containing compounds: adenine, cytosine, 
guanine, thymine and uracil. The polymerization of nucleotides is held by the 
phosphodiester bonds between the phosphate groups at the 5'C position and the OH group 
at the 3'C position of pentose sugar. Unlike the prokaryotes, eukaryotic genome is 
organized in a nucleus; therefore, it is necessary to provide a substance that can arrange 
and anchor the DNA double helix. In the discovery of nucleic acids, Albrecht Kossel also 
showed that a protein portion was present in the isolated substance "nuclein", which he 
later termed as "histon" (Campos and Reinberg, 2009). Under the eukaryotic 
physiological conditions, approximately 147 base pairs of DNA wrap around a 
positively-charged octamer protein, which comprises of two copies of histones: H2A, 
H2B, H3 and H4. This structure is termed "nucleosome". Nucleosomes are organized into 
higher-order structures by linking to histone H1 with extra 10-70 base pairs of DNA. In 
1976, evidence of higher-order structure than nucleosome was observed by John Finch 
and Aaron Klug and was later termed "solenoid". To date, no other higher-order structure 
beyond solenoid has been reported with clear evidence (Kornberg, 1974; van Holde et al., 
1974; Woodcock, 2005).  
 
The average size of a nucleus is approximately 10 micrometers in diameter, whereas the 
total length of DNA in human cells is around 2 meters. The mechanism of fitting the 
entire human genome into a nucleus is still poorly understood. In a nucleus, chromatin is 
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the highest order that results in DNA compression to date. Typically, a base pair in a 
DNA double helix is approximately 2 nanometers in width. Nucleosome core, which 
contains both DNA and histone cores, has a diameter of around 11 nanometers. Six 
nucleosomes join by histone H1, which results in a structure called solenoid that is 
approximately 30 nanometers in diameter. It is believed that from the solenoid, a 300-
nanometer loop can be formed and further compressed into a 250-nanometer fiber. 
Hypothetically, a folding and tightening process after the 250-nanometer stage is required 
to construct a 700-nanometer chromatid, then a 1400-nanometer chromosome (Figure 
1.1).  
 
Figure 1.1: Eukaryotic genome compaction and organization. Hypothetical 
illustration of the compression of DNA double helix to chromosome (Annunziato, 2008). 
A total of 6.6*109 base pairs of DNA is folded and compressed into a 10-micrometer 
nucleus. 
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1.2 Histone post-translational modifications and epigenetics 
The reason that prokaryotes, such as bacteria, do not have nucleosomes is because they 
lack the structural protein - histones. There are four core histones: H2A, H2B, H3 and H4, 
and one linker histone H1. Except for histone H1, all four core histones have about 25% 
of its mass weighted in the N- and C- terminal domains.  
Although these terminal domains do not provide structural functions, they can be 
modified to regulate gene expression (Figure 1.2). Histone post-translational editors are 
able to directly modify these histone tails while chromatin-binding proteins recruit other 
transcriptional complexes for gene expression (Wolffe and Hayes, 1999).    
 
 
Figure 1.2: 2D depictions of four core histones and modifications. Histone 
modifications mostly take place in N- and C- terminal domains with the exception of 
histone H3 K56 and K79 positions. The modification code ac, me, ph and ub1 stand for 
acetylation, methylation, phosphorylation and ubiquitination respectively (Bhumik et al., 
2007).  
Histone modifications have been known primarily since the 1960s, when Dr. Vincent 
Allfrey at Rockefeller University postulated that histone acetylation may be involved in 
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RNA synthesis (Allfrey et al., 1964). Although the histone post-translational 
modifications (PTMs) is just one aspect of epigenetics, in the past 50 years, this field has 
grown massively along with the human ROADMAP epigenomics project. In fact, without 
the current progress of epigenetics, understanding and utilizing the ENCODE data would 
be more complicated. The concept of epigenetics was first mentioned in the 1940s by 
Conrad Waddington. The original idea of epigenetics was described as a biological 
phenomenon of heritable regulatory mechanism in gene expression that is independent of 
changes of the DNA sequence. Chromosome remodeling (ie: Xist), protein PTMs (ie: 
histone modifications), DNA methylations and ncRNAs related regulations (ie: miRNA 
silencing) are some of the examples of epigenetics (Woffle and Matzke, 1999).  
 
 
Figure 1.3: Major epigenetic mechanisms that alter gene expression. Histone 
modifications and DNA methylations directly regulate gene transcription whereas non-
coding RNA such as micro-RNA inhibits mRNA translation (Kim, 2014).  
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1.3 Histone code 
Like many other PTMs, histone modifications work coherently. The histone code 
hypothesis was first made by Strahl and Allis (Figure 1.4). The rationale behind the 
histone code hypothesis is based on some contradictory functions of certain histone 
modifications. For example, H3S10ph was first found to be a repressive mark during 
mitosis (Hendzel et al., 1997). However, it was also reported with activation functions 
upon mitogen stimulation (Thomson et al., 1999). This one modification exhibits 
paradoxical functions, implying that there is a potential mechanism that either 
overpowers this mark or alters its function. In fact, the latter scenario was evidenced by 
ChIP analysis with specific antibodies for both K9ac/S10ph and H3S10ph/K14ac. Both 
combined PTMs display transcriptional activation upon mitogen stimulation while 
acetylation becomes the major driver. Missing H3S10 phosphorylation delayed the 
acetylation process and therefore repressed gene expression (Cheung et al., 2000 and 
Clayton et al., 2000).  
 
Figure 1.4: Histone modifications that are acting in concert. Normally, histone 
methylation occurs on arginine and lysine residues; acetylation occurs on lysine; 
phosphorylation takes place on serine. Combination of histone modifications require a 
complex reader (either multiple domains or proteins) to recognize them (Strahl and Allis, 
2000).  
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1.4 Histone modification enzymes and epigenetic editors 
The first histone modification enzyme was discovered on acetylation. In 1996, both 
histone acetyltransferase (HAT) and histone deacetylase (HDAC) were identified. The 
first HAT was identified as a homologue of the yeast protein Gcn5, which is a putative 
transcriptional activator. As a nuclear A-type HAT, it has a conserved acetyllysine-
binding bromodomain that is not present in the cytoplasmic B-type HATs. Hence, it was 
also the first study that linked transcriptional activation to A-type HAT mediated 
acetylation (Brownell et al., 1996). In contrast, the discovery of the first HDAC was 
identified as a homologue to the yeast transcriptional repressor protein Rpd3p. As a result, 
histone deacetylase was first linked to eukaryotic transcriptional repression (Taunton et 
al., 1996). Subsequently, great interest arose in the field of histone editors, resulting in a 
major breakthrough in the chromatin field in late 1990s. The discovery of histone kinases 
took place in 1999 by multiple groups; histone arginine and lysine methyltransferases 
were found in 1999 and 2000 respectively; and histone ubiquitin ligase was identified in 
2000 (Jin et al., 1999; Thomson et al., 1999; Chen et al., 1999; Rea et al., 2000 and 
Robzyk et al., 2000). 
In addition, many histone modification recognition domains – such as acetyllysine-
binding bromodomains, methyllysine binding chromodomains, plant homeodomains and 
Tudor domains – were identified in the late 1990s (Figure 1.5). Multiple histone 
modification readers were reported to be working in the complex for transcriptional 
regulation, suggesting a higher-order of histone code cross-talking was present. For 
example, the methyllysine-binding plant homeodomain containing finger protein 6 (PHF6) 
was co-purified with the nucleosome remodeling and deacetylation (NuRD) complex, 
which is known for transcriptional repression (Liu et al., 2015).   
To date, most of the histone modifiers and readers are called the epigenetic "readers", 
"writers" and "erasers" (Figure 1.6); although many of them have now progressively 
been identified with non-histone-binding and -modifying properties in cellular signal 
transduction. Notably, the study of epigenetics, especially PTMs, is no longer limited to 
histone proteins (Biggar and Li, 2015). 
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Figure 1.5: Common histone modification readers for methyllysine, methylarginine, 
acetyllysine, phosphorylated serine and threonine. Most methyl-binding domains 
contain an aromatic cage that interact specifically with methyllysine and methylarginine 
by hydrophobic and cation-pi interactions. Some PHD fingers can bind to both 
methyllysine and unmodified lysine. Acetyllysine is normally recognized by a highly 
conserved asparagine with hydrogen bonds. Histone phosphorylation is recognized by 
both hydrophobic interaction and hydrogen bonding with arginine (Musselman et al., 
2012).  
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Figure 1.6: Major players in epigenetics - "Readers", "Writers" and "Erasers". 
Although many histone modification editors are found having non-histone catalytic 
activities, this figure is referring to enzymes that modify only histone proteins. Besides 
the enzyme showed here, other known histone "writers" and "erasers" include histone 
kinases/phosphotases, ubiquitin ligases, sumoylation ligases, ADP-ribosyltransferases 
and deiminases. Many of the histone "writers" and "erasers" in fact have "reader" 
property for detecting specific modifications (Falkenberg and Johnstone, 2014). 
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1.5 KDM5B/JARID1B and related diseases 
The histone lysine demethylase KDM5B/JARID1B is a member of the KDM5/JARID1 
family. All four family members of JARID1 contain JmjN and JmjC domains for 
demethylation, and ARID and Zinc finger binding domain for DNA binding. However, 
the type-3 PHD domain is missing in both KDM5C/JARID1C and KDM5D/JARID1D in 
humans. To date, the only known histone substrate of KDM5B is histone H3K4 mono-, 
di- and trimethylations (Klein et al., 2014). KDM5B is known to be an oncoprotein as its 
expression is usually limited in most normal tissues besides testes and ovaries. 
Upregulation of KDM5B is commonly found in various human cancers such as breast, 
prostate, lung and cervical cancers (Hayami et al., 2010). Recent studies also reported 
that KDM5B is linked to cancer stemness and hypoxia response (Lin et al., 2015 and 
Salminen et al., 2016). 
The most well-studied KDM5B-related disease is breast cancer. Data was observed in 
previous breast cancer studies, suggesting that the functions of KDM5B in different types 
of breast cancer could be opposite. For example, in ER+ breast cancer cell lines such as 
MCF7, KDM5B overexpression promoted cell proliferations whereas in ER- MDA-MB 
231 cells it suppressed cell proliferations (Hayami et al., 2010 and Yamane et al., 2007). 
This bivalent behavior suggests that KDM5B may be associated with transcriptional 
regulatory complexes in a cell-type-dependent manner (Klein et al., 2014). 
 
1.6 Plant homeodomains of KDM5B 
As mentioned above, the KDM5/JARID1 family has relatively conserved constituents. 
The major difference among all family members is the number of PHD domains. 
KDM5B has a complete set of PHD domains in the KDM5 family (Figure 1.7) and its 
molecular weight is about 180 kDa. The type-1 PHD domain is located between the 
ARID DNA binding domain and JmjC domain. The type-2 PHD domain and type-3 PHD 
domains are placed in tandem after the Zinc finger binding domain. Recent study 
identified that the type-1 PHD domain of KDM5B has preferential binding to unmodified 
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histone H3K4, whereas the type-3 PHD domain preferentially binds to histone 
H3K4me2/3(di- and trimethylation). Surprisingly, the type-2 PHD domain has no binding 
specificity to most of the common histone marks, such as histone H3K9, K27, K36, K79 
and the histone H4K20. Yet, binding partner of type-2 PHD domain in KDM5B has not 
been defined (Klein et al., 2014).   
 
1.7 H3K4me2/3 demethylation by KDM5B  
Since the type-3 PHD domain of KDM5B binds to its substrate, it suggests that there is 
an uncommon demethylation mechanism for the H3K4me2/3. One hypothetical model 
suggested that both type-1 and type-3 PHD domains need to be anchored into their 
binding partner for the dimerized JmjN and JmjC domains to catalyze demethylation. 
However, in this model, the ARID, Zinc finger binding domain and type-2 PHD do not 
have any binding partners (Figure 1.8).  
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Figure 1.7: Illustration of architectures of KDM5/JARID1 family in human, fruit fly 
and yeast. The first four components from the N-terminal are most conserved among all 
KDM5/JARID1 members. Also, high sequence homology of PHD1 indicates that the 
binding mode of H3K4me0 by PHD1 is the most conserved.  
 
 
Figure 1.8: Hypothetical KDM5B substrate (H3K4me3) binding model. The coloured 
K4m circle represents histone H3K4 trimethylation while the K4 circle is unmodified 
H3K4. The hypothetical mechanism takes place not on the PHD3-bound H3K4me3, but 
on the adjacent nucleosomes that contain H3K4me3/2. During the demethylation, both 
PHD1 and PHD3 remain bound, while the catalytic JmjC domain slides alongside, 
searching for nearby substrates (Klein et al., 2014).  
12 
 
1.8 Stem cell biology and pluripoptency 
One significant breakthrough in stem cell biology came in 1981 when the first mouse 
stem cell line was isolated and maintained in a pluripotent state independently by Gail R. 
Martin and Matthew H. Kaufman (Martin, 1981; Evan and Kaufman, 1981). Since then, 
the field of stem cell biology flourished rapidly and led to comprehensive 
characterizations of stem cell potencies. Upon fertilization, oocyte quickly becomes a 
single-cell zygote and then a two-cell zygote with the unique activation of its zygotic 
genome, which is dependent on the typical cytoplasmic environment of oocyte. 
Accumulated evidence suggested that totipotency starts depleting from the two-cell (2C) 
stage to early morula (about 8 to 16 cells). Also, cells isolated after the 2C stage have not 
been successfully developed into a fully functional organism (Lu and Yi, 2015). Embryo 
beyond early morula is considered plenipotent until early blastocyst. Mouse embryonic 
stem cells (mESCs) are isolated from the inner cell mass (ICM) of blastocyst embryo 
(Condic, 2014). Cells at this stage are now widely considered pluripotent, that is, being 
able to differentiate into any cell types that are found in a mature organism (Figure 1.9).  
The major challenge in culturing stem cell is maintaining pluripotency because in routine 
culture media, stem cells undergo spontaneous differentiation once they are isolated from 
ICM. The first successful attempt used the combination of fetal calf serum and mouse 
embryonic fibroblast (MEF) feeder layers (Martin, 1981; Evan and Kaufman, 1981). 
However, at that time, the substances that inhibit stem cell differentiation were not 
defined, and therefore this practice was highly variable. In late 1980s, Leukemia 
inhibitory factor (LIF) was first confirmed to have differentiation inhibitory activity as 
LIF was isolated from Buffalo-rat liver (BRL) cells that were used to substitute MEF 
(Smith and Hooper, 1987; Moreau et al., 1988). Since then, LIF/serum became a routine 
medium for culturing stem cell although some mouse embryonic stem cell lines are 
strictly feeder dependent. Recently, a defined medium was found to have steady and a 
broad range of differentiation inhibitory effects. Instead of using serum, 2 small molecule 
inhibitors acting on Mitogen-activated protein kinases (MAPKs) and glycogen synthase 
kinase 3b (GSK3B) were used. This allowed all types of mESCs to retain pluripotency 
13 
 
without the need of feeder cells (Figure 1.10). This serum-free stem cell media is now 
referred to 2i/LIF (Ying et al., 2008). 
In 2006, Shinya Yamanaka and his colleagues demonstrated the regaining of pluripotency 
in reprogrammed somatic cells. The induced pluripotent stem cells (iPSCs), although 
inefficient, were the first evidence that somatic cells could be reprogrammed by the 
overexpression of four essential genes: Oct4. Sox2, Klf4 and c-Myc (Takahashi and 
Yamanaka, 2006). Later studies showed that this reprogramming did not require all four 
genes and they could be replaced (Okita et al., 2008). Also, co-expressing other 
transcription factors such as Zic3 and Esrrb with these four genes showed increased 
reprogramming efficiency (Sone et al, 2017). Together, these discoveries suggested some 
degree of redundancy in the maintenance of stem cell pluripotency.   
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Figure 1.9: Architectures of early embryonic development. A) Annotated human 
blastocyst at 5-6 days. Embryonic stem cells are taken from ICM, which are considered 
pluripotent but not plenipotent since they are not able to differentiate into either the polar 
trophectoderm (PE) or mural trophectoderm (TE). Cells descended from ICM also exist 
in postnatal life. Both TE and PE are considered as extraembryonic stem cells and they 
differentiate into placental tissues (gestational functions). B) Chronological development 
stage from single cell zygote to late blastocyst. Despite only 2-C stage showing totipotent 
here, totipotency can remain until early morula stage (8-16 cells). In the developmental 
timeline, plenipotent stem cells can turn into ICM, PE and TE, that is, both embryonic 
and extraembryonic stem cells (Condic,2014). 
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Figure 1.10: Schemes of LIF induced JAK -STAT signaling and 2i/LIF induced 
signaling. A) JAK-STAT activation by LIF. Upon LIF stimulation, PI3K-AKT, STAT3 
and MAP Kinase are activated. The activation of STAT3 by JAK is known to sufficiently 
maintain pluripotency. Activation of PI3K-AKT can increase proliferation. The 
activation of MAP kinase can trigger differentiation but this effect is overwritten by 
STAT3 activation. B) Differentiation inhibitory activity with MEK and GSK3b inhibitors. 
Prolong activation of MAP kinase can induce differentiation. By including MEK 
inhibitor, it reduces the risk of LIF-induced differentiation. GSK3 inhibitor is used to 
mimic the activation of Wnts, which can further stabilize beta-catenin. The downstream 
responder is TCF/LEF, which is important for c-MYC and cycD expression. (Melanie et 
al., 2011 and Ohtsuka et al., 2015) 
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1.9 The role of KDM5B in neurogenesis  
KDM5B/JARID1B has its known substrates H3K4me3/2, which are marks for gene 
activation. Since KDM5B removes H3K4 methylation, losing KDM5B/JARID1B can 
lead to potential latency of gene deactivation and misoriented gene expression. Complete 
knockdown of KDM5B is embryonic lethal between E4.5and E7.5, which is a relatively 
early embryonic stage right after implantation, suggesting severe developmental defects 
can take place (Catchpole et al., 2011). Recent transcriptional and ChIP analysis revealed 
that, depletion of KDM5B introduced significant upregulation of self-renewal genes, 
thereafter impairing the differentiation landscape. Interestingly, genome-wide study 
showed that KDM5B and its substrate H3K4me3/2 co-occurred at same promoters, 
indicating that KDM5B had sole chromatin binding ability besides its catalytic function. 
Also, it is reported that KDM5B occupies the promoters at Nanog and Oct4. However, 
KDM5B itself did not play a critical role in pluripotency maintenance or self-renewal 
(Kidder et al., 2014; Schmitz et al., 2011 and Xie et al., 2011).  
Previous study found that KDM5B knockdown greatly impairs neuronal differentiation in 
mESCs by blocking the expression of genes in the neuronal axis, therefore resulting in 
the abnormal formation of embryoid bodies (Dey et al., 2008). Transcriptional studies 
identified that self-renewal associated genes of KDM5B knockdowns such as Oct4 and 
Nanog failed to downregulate during differentiation, which is in line with the previous 
findings. Cells with KDM5B knockdown do not pass differentiation day 8 after retinoic 
acid induction, and no apparent neuronal networks were observed. In contrast to the early 
knockdown, induced knockout of KDM5B after E12.5 show little to no effect to cell 
survival and later neuronal development. Intriguingly, the induced knockout of KDM5B 
also displayed no effect on H3K4me3 level, suggesting that demethylation of 
H3K4me3/2 by KDM5B acts in a developmental stage dependent manner (Schmitz et al., 
2011).  
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1.10 Previous study and preliminary data 
 
Discovery of H2BK43me2 
A previous study from our group in 2010 showed that methylated H2BK43 interacts with 
chromatin binding-modules (CBMs). Although the reason this location was chosen for 
study was not well explained, CBMs binding of this site were found to preferentially 
occur on dimethyllysine but not on mono- or trimethyllysine (Liu et al., 2010). Also, in 
our recent unpublished data, H2BK43me1 was predicted to be a potential histone 
methylation site with high confidence (P-value 0.824, Table 6) by deep learning 
algorithms (Biggar et al., unpublished data).  
Although our previous works had provided biochemistry foundations, under cell 
physiological conditions, validation of KDM5B mediated H2BK43me2 demethylation 
was still required. Unlike histone H3 and H4, histone H2B has relatively shorter N-
terminal tail. Many of the well-studied sites on histone H3 are located at its N- or C 
terminal, such as K4, K9, K27, K36 and K79, where they are freely accessible by other 
transcription factors or modification enzymes (Bhumik et al., 2007). However, 
H2BK43me2 is located in its globular domain bound by the DNA double helix, which 
means it has less exposure to nucleoplasm. In fact, X-ray crystallography of histone H2B 
showed that lysine at position 43 is placed very close to the phosphodiester backbone 
(Figure 1.11), indicating there may be a binding between K43 and the DNA double helix 
which also limits its exposure to proteins in the nucleoplasm. Nevertheless, in our 
previous study (Figure 1.12), nucleosomes were dissolved in 1M guanidine 
hydrochloride (pH 7.6). Although this is not an extremely harsh condition, DNA double 
helix may be interrupted and H2BK43me2 exposed.  
Our aim here was to confirm that histone H2BK43me2 was a true substrate of KDM5B 
under cell physiological conditions. To solve this problem, we adopted both human breast 
cancer cell lines and mESCs. Many studies showed that KDM5B was playing important 
roles in neuronal differentiation (Dey et al., 2008 and Schmitz et al., 2011). If 
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H2BK43me2 is one of the targets of KDM5B, its methylation level should be affected by 
the expression of KDM5B. Also, KDM5B overexpression is reported in MCF7 breast 
cancer cells (Bamodu et al., 2016). KDM5B knockdown in MCF7 cells may cause 
accumulation of H2BK43me2. Therefore, these two systems are suitable for examining 
whether H2BK43me2 is a substrate of KDM5B or not.  
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Figure 1.11: Structure of nucleosome in cartoon representation (PDB code 5AV8). A) 
H2A (grey and purple) - H2B (grey and pink) dimer associated with DNA double helix 
(beige) with lysine at position 43 of H2B showed in red stick. DNA double helix wind 
around the H2A – H2B dimer, thus making the H2BK43 less accessible to other proteins. 
B) Close-up image showing distance (indicated by dashed line) between H2B lysine 43 
(red) and DNA double helix (cyan). The shortest distance between the positively charged 
ε-ammonium group and the negatively charged phosphodiester backbone (orange) is 
measured as 3.4 angstrom, suggesting there is potential for an interaction.   
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H2BK43me2 as a preferred substrate of KDM5B in vitro 
Since we predicted that KDM5B may have an alternative substrate other than H3K4me3, 
we further screened peptides listed in our 2010 publication. Surprisingly, previous results 
from our group could not confirm histone H3K4me3 was the preferred substrate of 
KDM5B; instead, our data suggested that H2BK43me2 was the preferred substrate of 
KDM5B compared to H3K4me3 in vitro (Figure 1.12 and Figure 1.13).  
The histone binding pattern of KDM5B had been examined recently (Figure 1.14). So far, 
most of known sites were identified on histone H3 and H4; yet not many studies had been 
done on histone H2B. Knowing that KDM5B could catalyze H2BK43me2 demethylation 
did not unveil enough details of how this recognition was achieved. Therefore, to 
complete the biochemistry study, we aim to elucidate the binding mechanism between 
KDM5B and H2BK43me2.  
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Figure 1.12: H2BK43me2 is an alternative substrate of recombinant KDM5B in 
vitro. A) Quantitative MS analysis reviewed substrate demethylation ratio. r. KDM5B 
was used to catalyze demethylations of synthetic peptides. After 60 minutes of reaction, 
remaining peptides were quantized by MS analysis. Bars represent the percentage of 
substrates catalyzed by r.KDM5B.  H3K4me2 and H3K4me3 served as positive control 
in this analysis. B) r.KDM5B acted on purified nucleosomes. Purified nucleosomes were 
incubated with different amount (0, 0.1 and 1 g) of r.KDM5B for 60 minutes. After 
reaction, proteins were separated by SDS-PAGE and stained with corresponding antibody 
for western blot analysis. Pan-H3 was used as reference of loading amount (Stalker et al., 
unpublished data).    
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Figure 1.13: H2BK43me2 is a substrate of KDM5B under cell physiological 
conditions. A) KDM5B downregulation during neuronal differentiation. mESCs were 
induced to neurogenesis in specific media for 7 days. Total cell lysates were collected at 
day 0, 3, 5 and 7 for immunoblotting. Beta-actin was used as reference of loading amount. 
B) Accumulation of H2BK43me2 during neuronal differentiation. Same neuronal 
induction process was conducted but histone extracts were only collected at day 0, 5 and 
7 for immunoblotting. Pan-H3 was used as reference of loading amount. C.) Quantitative 
MS analysis of H2BK43me2 level during differentiation in KDM5B knockdown and WT 
cells. Histone extracts collected at day 0 and 5 were sent for MS-MRM analysis to 
determine relative amount of H2BK43me2 in both WT mESCs and KDM5B knockdown 
mESCs. Bars represent the relative amount of H2BK43me2 to the corresponding 
H2BK43me2 standard peptide (Stalker et al., unpublished data).   
.  
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Figure 1.14: Pull-down analysis of binding preference of different KDM5B PHD 
domains. PHD domains were pulled down by streptavidin beads with biotinylated 
histone peptides. KDM5B PHD1 domain bound to unmodified H3 (aa 1-21) regardless of 
the condition of H3K9 methylation. KDM5B PHD2 domain had no known histone 
binding partner. KDM5B PHD3 domain specifically interacted with H3K4me3/2 (Klein 
et al., 2014). 
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1.11 Hypothesis and aims 
Given the fact that KDM5B mediated H3K4me3/2 demethylation is conditional and both 
KDM5B and H3K4me3/2 have same promoter occupancies, we hypothesize that there is 
an alternative chromatin binding partner or substrate of KDM5B present. To test our 
hypothesis, we used synthetic peptides to search for potential binding partners of 
KDM5B. Also, we investigated all three PHD domains of KDM5B separately to dissect 
the biochemistry of the binding partner recognition mechanism. To this end, we applied 
both peptide pull-down assay and fluorescence polarization assay. We also extended our 
research into cell physiological conditions. We generated both stable and transient 
KDM5B knockdown cell lines as well as differentiated stem cells to study the dynamics 
of histone methylation. 
 
Our aims: 
1. To identify the alternative binding partners of KDM5B 
2. To examine whether KDM5B mediates demethylation of its alternative binding 
partners.   
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Chapter 2 
Methods and results 
2.1 Methods 
2.1.1 Bacterial culture and protein purification 
All three PHD domains (PHD-1, aa303-363; PHD-2, aa 1168-1239 and PHD-3, aa 1481-
1538 of human KDM5B - UniProtKB -Q9UGL1) that were cloned into vector pGEX-6P-
1 (gifts from Dr. Shi Xiaobing). In brief, plasmids amplified in E. coli DH5- were 
purified using EZ-10 Spin Column Plasmid DNA Miniprep Kit (Bio Basic) according to 
manufacturer's instruction. Proteins were expressed in E. coli Rosetta-2 DE3 (Novagen) 
with Ampicillin (50 g/ml) and Chloramphenicol (20 g/ml) selection in Luria Broth 
(Bio Basic). Before induction, bacterial concentration was measured by OD600 in the 
range of 0.6~0.8 A; 0.5 mM IPTG and 150 M ZnCl2 were used for induction. After 
incubation at 18oC for 16 hours, bacteria were first pelleted by 8000 rpm centrifugation at 
4 oC for 20 minutes then washed twice with ice-chilled PBS. Cell pellets were lysed by 1% 
Triton-X100 (Sigma), 10 unit/ml benzoase (Sigma), 1mg/ml lysozyme (Bio Basic), 1 mM 
PMSF in PBS at 4 oC with mild agitation for 1 hour. Clear bacterial lysates were 
collected by 12000 rpm centrifugation at 4 oC for 20 minutes. GST-tagged proteins were 
then purified on Glutathione Resin (GenScript) following manufacture's instruction. 
Eluted proteins were dialyzed in 20 mM Tris pH 7.4, 140 mM NaCl and 1 mM 
dithiothreiol (DTT) at 4 oC overnight. Purified GST-tagged proteins were either 
concentrated by 10 kDa filters (Amicon) or used directly after concentration 
measurement. The quality of proteins was assessed by Coomassie staining SDS-PAGE.  
2.1.2 Peptide synthesis 
Peptides were synthesized on Tentagel resins (Intavis) by Intavis-AG MultiPep peptide 
synthesizer with Fmoc (N-(9-fluorenyl) methoxycarbonyl) chemistry (Carpino and Han 
1970). In brief, peptides were synthesized in 2 mol scale from their C-terminal. Either 
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biotin or 6-Carboxyfluorescein were attached to the 6-aminohexanoic acid at the N-
terminal, enabling these peptides to pull-down and fluorescence polarization experiments. 
Post-synthetic peptides were cleaved by mixture of trifluoroacetic acid (TFA) and 
triisopropysilane (TIPS) then precipitated in -20 oC ether following manufacture's 
instruction. Peptide pellets were washed again with -20 oC ether twice and dried in fume 
hood before resuspended in distilled water. List of peptides used in this study were 
showed in Table 1. 
2.1.3 Matrix Assisted Laser Desorption/Ionization (MALDI) 
Quality of synthetic peptides were assessed by MALDI-TOF using Micromass M@LDI 
mass spectrometry (Waters). Briefly, 1 l of undiluted peptide solution was mixed with 1 
l of provided matrix (10 g/l -cyano-4-hydroxycinnamic acid in 3/5 CH3CN/1% 
formic acid v/v). 2 l of mixtures was doted and air-dried on MALDI plate before 
analyzed by mass spectrometer (see appendix A for example). 
2.1.4 Mammalian cell culture and subcellular fractionation 
MCF7 cells were culture in DMEM (Sigma) supplemented with 10% FBS (Wisent), 2 
mM L-glutamine (Gibco), 100 U/ml penicillin-streptomycin (Gibco), 2 mM sodium 
pyruvate (Gibco) at 37 oC humidified incubator with 5% CO2. Cells were passaged at 
subconfluent condition (80%) to avoid senescence. Cells were wash with room 
temperature PBS before using 0.1% trypsin (Gibco) for 5 minutes at 37 oC. Subcellular 
fractionation protocol was mainly adopted from Schechter et al.. In brief, trypsinized 
cells as described above were first wash with ice-chilled PBS twice at 1000 rpm for 5 
minutes. Cell pellets were lysed in ice-chilled hypotonic buffer (1 * 107 cells/5ml) 
containing 10 mM Tris-Cl pH 7.4, 3 mM KCl, 1.5 mM MgCl2, 0.1 % NP40 and 1 mM 
PMSF at 4 oC with mild agitation for 10 minutes. Supernatant (S1) was collected as 
cytoplasmic fraction by spinning at 2100 rpm, 4oC for 5 minutes. Pellets after the first 
lysis containing mainly nucleus were further lysed by 3 mM EDTA, 0.2 mM EGTA, 1 
mM PMSF and 0.2 % Tween-20 (Sigma). Supernatant (S2) was saved as nucleoplasmic 
fraction by spinning at 10000 rpm, 4 oC for 10 minutes (Schechter et al. 2007). Combined 
S1 and S2 was used for histone peptide pull-down analysis.  
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2.1.5 GST and streptavidin pull-down analysis 
Histone peptide pull-down protocol was adopted from a publish protocol with minor 
modifications (Figure 2.4). In brief, biotinylated histone peptides were first incubated 
with ice-chilled PBS washed streptavidin beads (GE) at 4oC with mild agitation for 2 
hours. 10g of peptides was immobilized by 40l slurry. Subsequently, pre-bind beads 
were washed with ice-chilled PBS twice then PBS-T once. Beads were washed at 4oC, 
500 rpm. Beads were then resuspended in enough PBS with 1mM PMSF to achieve 50% 
slurry prior to use. For the subcellular lysate pull-down, lysates were pre-cleared by 
adding streptavidin beads (10l slurry to 1ml lysate) and incubate at 4oC with mild 
agitation for 1 hour. Pre-cleared lysates were subsequently mixed with different histone 
peptide conjugated streptavidin beads and incubate at 4oC with mild agitation overnight. 
For the purified GST-tagged protein pull-down, pre-cleared GST-tagged proteins were 
first incubated with different histone peptides at 4 oC with mild agitation overnight (10 
g peptides to 1 mg protein). Peptide-protein complexes were then pull-down by adding 
streptavidin beads (40 l slurry to 10 g input peptides) at 4 oC with mild agitation for 2 
hours. Beads were later collected at 4 oC, 500 rpm and washed twice with ice-chilled 
buffer containing 20 mM Hepes pH 7.9, 200 mM KCl, 0.1% Triton-X100 and 1 mM 
PMSF. Proteins on beads were eluted by boiling in 2X Laemmli buffer for 5 minutes 
(Wysocka, 2006). 
 
2.1.6 SDS-PAGE and Coomassie staining 
SDS-PAGE and Coomassie stain recipes were obtained from protocols published by Cold 
Spring Harbor Laboratory. Typically, 10% gels were used for protein separation. 
Running condition for SDS-PAGE was 120 V for 15 minutes following by 180 V for 45 
minutes (Bio-Rad Mini-Protean) in 1X Towbin buffer. Gels were then incubated with 
Coomassie stain at room temperature for 30 minutes and destained in water overnight.  
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2.1.7 Western blot 
After running SDS-PAGE, gels were transferred onto methanol activated PVDF 
membrane in 1X Towbin buffer plus 10% methanol via Trans-Blot® Semi-Dry (Bio-Rad) 
using constant milliampere (1 mA per cm2) for 90 minutes. Transferred membrane was 
first block with TBST plus 2% BSA for 1 hour at room temperature with mild agitation. 
Blocked membrane was then probed with TBST, 1% BSA and 0.1% sodium azide diluted 
primary antibody according to specific working dilution. Typically, primary incubation 
was carried out at 4 oC with mild agitation overnight. Membrane was then washed with 
TBST twice for 10 minutes at room temperature with mild agitation before adding 
secondary antibody (1:2500 dilution in TBST plus 2% milk) and incubated for 2 hours at 
room temperature with mild agitation. After secondary incubation, membrane was 
washed again with TBST twice for 10 minutes at room temperature with mild agitation. 
Finally, membrane was developed using home-made substrate at room temperature for 2 
minutes (solution A: 2.5 mM Luminol, 400 M p-Coumaric acid and 100 mM Tris-Cl 
pH8.8; solution B: 0.02% Hydrogen Peroxide in 100 mM Tris-Cl pH8.8, all chemical 
purchased from Sigma). Images were taken with ChemiDocTM XRS+ system (Bio-Rad).  
2.1.8 Fluorescence polarization assay 
Dialyzed GST-tagged proteins were adjusted concentration to a master stock of 200 M. 
Different concentration of GST-tagged proteins were made from master stock. 6-FAM-
tagged histone peptides concentration were measured according to fluorescence intensity. 
In principle, fluorescence signal intensity in each well was adjust to between 20000 to 
60000 units when measuring emission at 520 nm with 35 l total volume in 384-well 
plate on Perkin-Elmer 2103 multilabel plate reader. Adjusted histone peptides were 
incubated with GST-tagged proteins in dark for 10 minutes before taking fluorescence 
polarization measurement. Fluorescence polarization measurement was taken with 480 
nm excitation and 520 nm emission. Biding curves and corresponding dissociation 
constants (Kd) were generated by Prism 3.0 software (GraphPad software, Inc.). 
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2.1.9 Mass spectrometry 
Histone extraction was performed as describe below. Briefly, 20 g histone extract was 
added in ABC pH 7.9 buffer. MS-grade Trypsin (Promega) was used for digestion 
according to manufacturer’s instructions. Digested mixtures were cleaned by homemade 
C-18 column using Empore C18 Disk and subsequently eluted by 70% ACN in MS-
Grade acidified water with 0.15 formic acid (Fisher). Elutes were then dried using 
speedvac to remove ACN residue. Prior to injection, samples were redissolved in MS-
grade water with 0.1% FA. Mass spectrometry was carried on the Q Exactive Hybrid 
Quadrupole-Orbitrap (Thermo) using an EASY-Spray Column PepMap RSLC (C18, 75 
M x 500 mm) in 100% ACN and 0.1% FA. Data collected was processed by PEAKS 
(Bioinformatics Solution Inc.)   
2.1.10 Cell culture and neuronal differentiation  
Cell culture protocol for MCF7 cells was same as the method mentioned in the former 
chapter. Mouse embryonic stem cells E14 were cultured using feeder-independent 
protocol (Bibel et al., 2007). In brief, mESCs were cultured on 0.1% gelatin-coated tissue 
culture treated dishes in DMEM (Sigma) supplemented with 15% ES grade FBS (Wisent), 
2 mM sodium pyruvate (Gibco), 2 mM L-glutamine, 100 U/ml penicillin-streptomycin 
(Gibco), 0.1 mM 2-mercaptoethanol (Sigma), 1X NEAA supplement (Gibco) and 1000 
U/ml LIF (Stem cell biotechnology), at 37 oC humidified incubator with 5% CO2.  Cells 
passaged at sub-confluent stage of 70% to avoid stem cell colonies touching each other. 
To passage, cells were first washed with PBS with 0.1 mM EDTA twice. Typically, 1 ml 
of 0.1% Trypsin was added to a 10-cm dish with 5 minutes incubation at 37 oC. Complete 
dissociation of clumps should be achieved to avoid spontaneous differentiation after 
passage. Neuronal differentiation protocol was adopted from our lab protocol. mESCs 
were grown in mESC media until cells became highly proliferative (doubling time less 
than 20 hours). Highly proliferative mESCs were lifted and 4 x 106 cells were seeded in 
bacterial Petri dish with 10 ml embryoid body media containing DMEM, 1% FBS 
(Gibco), 1X B-27 supplement (Gibco), 2 mM L-glutamine, 1X NEAA supplement, 100 
U/ml penicillin-streptomycin and 2 mM sodium pyruvate. Cells were left untouched for 
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48 hours to allow formation of embryoid bodies. Embryoid bodies were then plated onto 
1% gelatin coated tissue culture treated dishes (1:4 ratio) with neuronal differentiation 
media consisting of 5% FBS, 1X B27 supplement, 2 mM L-glutamine, 100 U/ml 
penicillin-streptomycin and 2 mM sodium pyruvate. Cells were maintained in this 
condition for further differentiation days.  
2.1.11 Histone extraction 
We followed the histone extraction strategy from Shechter et al. with minor 
modifications. Cells were first collected by washed by ice-chilled PBS twice to remove 
FBS completely. Typically, 1 x 107 cells were lysed with 5 ml ice-chilled lysis buffer 
containing 0.5% NP40 (Sigma), 10 mM Tris-Cl pH 7.6, 140 mM NaCl, 1.5 mM MgCl2, 1 
mM PMSF, on ice for 10 minutes with occasion inversions. Nuclei were pelleted by 
centrifugation at 2100 rpm, 4oC for 5 minutes. 1 ml of 0.4N H2SO4 was added to the 
pellet and then incubated for 1 hour on ice. Supernatant was collected by centrifugation at 
10000 rpm, 4oC for 5 minutes. In a new Eppendorf tube, mix 250 l of 100% TCA (w/v) 
with each 1 ml of supernatant for about 30 minutes to precipitate the histone proteins. 
Precipitates were pelleted by centrifugation at 14000 rpm, 4oC for 10 minutes. Pelleted 
histones were first washed by acidified acetone (0.01% HCl, stored at -20 oC) then twice 
with 100% acetone (stored at -20 oC). Lastly, the pellet was air dried and resuspended in 
water. Quality of histone was assessed by SDS-PAGE and Coomassie staining (showed 
in appendix C).  
2.1.12 Antibody validation 
Methyllysine antibodies were assessed by dot-blot assays using diluted histone peptides 
(Table 1). Typically, histone peptides were dotted on nitrocellulose membrane and dried 
at room temperature. Membrane was then blocked with 3% milk at room temperature for 
30 minutes and probe with corresponding antibody for two hours at room temperature 
subsequently. Procedures beyond this step were performed as regular western blot. 
Antibodies used in this study were shown in Table 5.  
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2.1.13 Plasmid purifications and cloning 
All bacterial cultures, except for lentiviral plasmids, for plasmid (Table 3) production 
were grown as describe above. The lentiviral pLKO.1 vector was amplified at 32 oC 
overnight before purification. Plasmids were purified as showed above. Plasmids which 
were used for electroporation - histone H2BK43WT-3x Flag, H2BK43-A-3x Flag and 
H2BK43-R-3x Flag - were cloned in pEGFP (with GPF portion removed). In brief, 
oligonucleotides of H2BWT and mutants were purchased from Bio Basic and digested 
with NheI and BamHI (Thermo) followed by T4 ligase (NEB) mediated ligation into 
pEGFP. Constructs were then sequenced using on campus service; redesigned sequences 
of H2BWT and mutants were shown in appendix D. KDM5B constructs were created by 
Gateway cloning using Gateway LR Clonase II (Invitrogen). KDM5B-pENTR3C was 
subcloned into both pMAX-DEST and pLenti-CMV-Puro-DEST followed 
manufacturer’s instructions. Plasmids for electroporation purposes were purified using 
QIAprep (QIAGEN) and manufacturer’s protocol was followed. Most of plasmids in our 
study were sequenced with exception for the KDM5B overexpression construct. 
2.1.14 Transfection and viral infection 
All shRNA and siRNA used in this study were listed in Table 2. For siRNA transfection, 
5 g of siRNA (Sigma) was mixed with 50 l X-tremeGENE siRNA transfection reagent 
(Roche) in 1 ml opti-MEM (Gibco) followed by 5 minutes incubation at room 
temperature. The mixture was added onto cells culturing in 6 cm dish to achieve total 
volume 2.5 ml. Transfection results were assessed after 72 hours incubation followed 
routine cell culture practices mentioned above. shRNA constructs were delivered by viral 
infection. In brief, Lentiviral particles were produced in HEK293T cells (provided by Dr. 
Zhao Lin). shRNA containing pLKO.1, packaging and envelop plasmids (1:2:2 molar 
ratio, Table 2) were delivered by X-tremeGENE HP transfection reagent (Roche) 
according to manufacturer’s protocol. Media was replaced 24 hours post-transfection; 
viral particles were collected 48 hours post-transfection and filtered through 0.44 m 
filter. Cells were infected with viral lysates with presence of polybrene (8 g/ml, Sigma) 
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and selected in puromycin media (3 g/ml, Invitrogen) 48 hours post-transfection for 5 
days. Due to the hard-to-transfect nature of mESCs, a combined method of 
electroporation and cationic transfection was used. Cells were harvested and pooled in 
ice-chilled Gene Pulse 0.4 cm cuvettes (Bio-Rad). Typically, 40 g linearized DNA was 
used in 1 x 107 cells in total volume of 1ml ice-chill PBS. Electroporation condition used 
was 220 V at 440 F for two pulses. Cells were resuspended fully before seeded onto 
MEF coated dish. A reversed transfection (see transfection procedures above) was also 
performed before cells completely attached to MEF. Typically, 10 g of linearized 
plasmids was used for 10 cm dish. Cells were selected 48 hours post-transfection for 7 
days using neomycin (500 g/ml, Bio Basic). For single cell colony isolation, cells were 
first limited diluted to 0.5 cells/well in 96-well plate. After 12 days incubation, single cell 
colonies were picked and transferred into 24-well plate supported with MEF for further 
expansion. Single cell colonies were examined by western blot to confirm the expression.  
2.1.15 RT-qPCR 
mRNAs were prepared using Absolutely Total and mRNA Purify Kits (Agilent) 
following manufacturer’s protocol. mRNA quality was evaluated by both OD260/280 
and 28S/18S ratio. To assess the integrity, crude mRNAs were loaded into 1% bleach 
agarose gel to look for degradation (example showed in appendix E). 2 g of mRNAs 
was reverse transcribed into cDNA using iScript cDNA synthesis kit (Bio-Rad). cDNAs 
were further diluted 1:40 in water for qPCR analysis. Typically, 2 l of diluted cDNAs 
were mixed with 6 l of iTaq universal SYBR supermix (Bio-Rad), 2 l ddH2O, and 2 l 
primer mix (3 M). We used the Hard-Shell 96-well PCR Plates (Bio-Rad) for loading 
and the Bio-Rad CFX connect for qPCR. Data process was completed via CFX Manager 
(Bio-Rad). All primers used in this study were listed in Table 4. 
2.1.16 Immunofluorescence and confocal microscopy 
For immunofluorescence, cells were grown on glass-bottom dishes (Corning) to about 30% 
confluent. Cells were first washed with PBS twice then fixed in 4% paraformaldehyde at 
room temperature for 10 minutes (4 ml per 60 mm dish). Fixed cells were washed with 
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PBS twice to remove paraformaldehyde and then permeabilized with 4 ml 0.2% Triton 
X-100 in TBS at room temperature with mild shaking for 5 minutes. Cells were blocked 
in 2% BSA in TBST for 1 hour. 200 l of diluted primary antibody (followed the 
antibody product sheets respectively) was added to the cells and then incubated at 37 oC 
in a humidified incubator for 1 hour. After incubation, cells were washed twice with 2% 
BSA in TBST then incubated with 200 l of diluted secondary antibody for 1 hour at 37 
oC. Cells were washed twice with 2% BSA in TBST before adding Vectashield antifade 
mounting medium with DAPI (Vector). Mounted dishes were covered with coverslips. 
Images were taken with LSM 880 with the Airyscan system (Zeiss) and processed via 
Zen Lite (Zeiss). All antibodies used in this study were listed in Table 4. 
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2.2 Results 
2.2.1  Protein purifications of GST-tagged KDM5B PHD domains                
In order to examine the binding mechanism of KDM5B PHD domains, cDNAs of 
different PHD domains were cloned into GST fusion vectors for purification. After 
induction, all three PHD domains showed more than one product in total cell lysates. 
GST protein itself has a molecular weight about 26 kDa and all three PHD domains are 
about 5.5 kDa. The purified product of PHD1 had two main bands at about 30 kDa and 
35 kDa; PHD2 had two main bands at about 26 kDa and 30 kDa. The PHD3 domain had 
only one major band, which was about 36 kDa. Smaller bands under 25 kDa were also 
observed in all three purified proteins (Figure 2.1). 
 
 
Figure 2.1: Coomassie staining of KDM5B - PHD1, 2 and 3 domains from E. coli 
Rosetta DE2. 1ml induced E. coli cells were directly lysed in Laemmli sample buffer and 
10ul per lane was loaded. 10ul of total 1ml eluted GST-tagged protein was loaded on 
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each lane. Protein marker from bottom to top was 20 kDa, 25 kDa, 35 kDa, 48 kDa, 63 
kDa and 75 kDa.  
2.2.2  Subcellular fractionation 
To ensure that histone proteins in cell lysate were not interfering histone peptide pull-
down, subcellular fractionation was performed. Coomassie staining showed that in both 
S1 and S2 fractions, proteins (bands) below 17 kDa were considerably less than total cell 
lysate. Chromosome fraction showed enriched histone proteins at around 17 kDa (histone 
H2A, H2B, H3 and H4) and 35 kDa (histone H1). Immunoblotting using anti-histone 
H2B indicated that histone H2B were only present in total cell lysate and P1 fraction 
(Figure 2.2).  
 
Figure 2.2: Subcellular fractionations. MCF7 cells were collected and fractionated into 
three different fractions. About 10 g of proteins was loaded in each lane. Upper panel 
was Coomassie staining on 12% SDS-PAGE. Same amount of protein was used for the 
western blotting showed in lower panel. 
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2.2.3  Histone H2BK43 interacted with KDM5B PHD domains 
Unlike PHD1 and PHD3, the PHD2 domain of KDM5B has not yet been reported with 
any binding partner. In the PHD1 and PHD3 binding study, only sites on histone H3 and 
H4 were examined, but not on H2B. Histone peptide pull-down assays of PHD3 
confirmed previous findings (Figure 2.3 B). In addition, histone H2BK43 peptides failed 
to pull down GST-tagged PHD3. H2BK43 was the only histone H2B peptide tested on 
two other PHD domains of KDM5B - PHD1 and PHD2. The PHD1 domain showed 
better binding on unmodified H2BK43 and H2BK43 dimethyl than monomethyl and 
trimethyl. The PHD2 domain showed strong binding on H2BK43 unmodified peptide and 
weak binding on three other methylation stages (Figure 2.3 and Figure 2.4). To evaluate 
the binding nature between KDM5B PHD domains and H2BK43 peptides, FP binding 
assays were performed using PHD1-H2BK43me0, PHD1-H2BK43me2 and PHD2-
H2BK43me0. However, PHD1-H2BK43me0 and PHD1-H2BK43me2 FP did not result 
in specific binding affinity reads (data not showed). For PHD2-H2BK43me0, the specific 
kinetic dissociation constant was 102 M.   
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Figure 2.3: Histone H2BK43 peptides interacted with KDM5B PHD domains in vitro. 
A) Schematic workflow of biotinylated histone peptide pull-down assay. Amount of 
histone peptides added was meant to saturate the capacity of streptavidin beads to 
minimize variation of peptide amount used. B) Histone peptide binding preference of 
PHD1, 2 and 3. PHD3. 10l of eluted proteins was loaded on each lane and both 
Coomassie gels and western blots were run in parallel on 12% SDS-PAGE. For western 
blot, transferred PVDF membranes were blocked with 3% non-fat milk in TBST before 
GST antibody incubation. C) Kinetic dissociation constant of PHD2 and H2BK43me0 
binding. Calculation was conducted based on two replicates. Concentrations used is this 
assay from low to high were: 0.54 M, 1.1 M, 2.18 M, 4.375 M, 8.75 M, 17.5 M, 
35 M, 70 M, 140 M and 160 M. 
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Figure 2.4: KDM5B was found in histone peptide pull-downs from cell lysate. A) 
Estimate of peptide concentration using Ponceau S staining. Peptides dissolved in H2O 
were diluted and 2l was dotted on nitrocellulose membrane. Membrane was stained with 
Ponceau S after air dried and subsequently rinsed with running water. Signal intensity 
correlated to peptide amount. B) Histone H3 N-terminal peptides interacts with more 
protein than H2BK43me2. Coomassie staining was performed on 12% SDS-PAGE gel. 
All four histone peptides could pull down proteins from fractionated cell lysates, 
regardless of efficiency. Due to the relatively low peptide concentration of H2BK43me2, 
double amount of peptide was used and comparable result was observed (appendix B). C) 
KDM5B interacted with histone H3K36me3 peptide. Western blot using anti-KDM5B 
was performed in the same loading amount as B. Membrane showed here was cropped at 
180 kDa. Original uncropped membrane is shown in appendix B. 
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2.2.4 Identification of H2BK43 methylations under cell physiological 
conditions 
To confirm the existence of H2BK43 methylation, we utilized mass spectrometry. 
Identification of histone post-translational modifications mainly relied on specific 
antibodies. Therefore, an alternative method such as mass spectrometry should be used to 
confirm western blot findings. In short, precursor ions and daughter ions were detected 
by MS/MS system and searched on pre-exist database. To H2BK43me1, y1 ion contained 
our target methyllysine, which has a molecular mass 161.13 Daltons. The detections of 
y2 to y7 ions also confirmed that the K43 lysine was monomethylated in its precursor ion 
ESYSVYVYK (Figure 2.5 A). To H2BK43me2, y1, y2 and y3 ions did not contain our 
target lysine. However, detections of dehydrated y5 and y7 ions confirmed that the K43 
lysine was dimethylated in its precursor ion ESYSIYVYKVLK (Figure 2.5 B). Note that 
the sequence of H2BK43me2 precursor ions belonged to the Type2-E variant of H2B, 
which is different from the Type1 C/E/G variants of H2BK43me1 precursor. Lastly, 
H2BK43me3 was also confirmed by its deaminated b13 ions from its precursor ion 
KESYSIYIYKVLKQVHPDTGISSK (Figure 2.5 C). This specific sequence was from 
the Type1-A variant of H2B. Detailed data of all detected ions is shown in appendix G.  
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Figure 2.5: Identification of in vitro H2BK43 methylations by MS/MS. A-C) Spectra 
showing H2BK43 mono, di and trimethylation. MS data collection and analysis were 
performed by Dr. Rui Wong. Typically, b ions were fragments obtained from N-terminal 
of its corresponding precursors (for example, b5 ions in B section had sequence ESYSI); 
y ions were fragments obtained from C-terminal of its corresponding precursors (y3 ions 
in B section had sequence VLK). Peaks of y and b ions with color labels were identified 
with high confidence.  
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2.2.5 Histone mutant H2BK43 to R showed deleterious effects on mESCs 
survival 
In order to examine the biological significance of H2BK43, we created two mutants 
H2BK43 to A and H2BK43 to R, to abolish and mimic the amino acid nature of lysine 
respectively. Our results indicate a relatively quick nucleosome integration of histone 
H2BK43 to A, comparing to WT H2B and H2BK43 to R (Figure 2.6 A). In addition, 
after single cell clone selection, expression of 3X FLAG WT H2B increased significantly, 
indicating that 3X FLAG WT H2B had also integrated into nucleosomes (Figure 2.6 A). 
However, while neomycin resistance was consecutively maintained in the H2BK43 to R 
mutant clones, anti-FLAG antibody failed to detect expression of FLAG tags, suggesting 
that no H2BK43 to R expression could be found in the cells (Figure 2.6 B).  
 
 
Figure 2.6: Histone H2BK43 to R was a potential deleterious trait for cell survival. 
A) mESCs stably expressing 3X FLAG H2BK43 to A mutant histones 7 days after 
transfection. Upper panel and lower panel were two different membranes. 5 g of each 
whole cell lysate samples was loaded on each lane. B) Selected single cell clones stably 
expressing 3X FLAG WT H2B histones but not H2BK43 to R mutants. Lower panel was 
a stripped membrane after probed with anti-FLAG.  
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2.2.6 KDM5B was downregulated at differentiation day 5, but not KDM5A 
and KDM5C 
Although complete knockout of KDM5B had shown embryonic lethality at E4.5, 
knockdown KDM5B in mESCs was successfully created and maintained. Among all 
KDM5B stable knockdowns we obtained, PLKO-sh91 had the lowest expression and 
displayed normal stem cell morphology compared to control (Figure 2.7 A and B). As 
expected, in PLKO-sh91, KDM5A expression was unaffected. Interestingly, from our 
RT-qPCR results, KDM5C was upregulated in about 2-fold while KDM5B was 
undetected (Figure 2.7 C). For the stem cell pluripotency markers, no significant 
increase of Nanog was detected and there was about 1.8-fold increase of Oct4 detected 
(Figure 2.7 C).  
We also examined the dynamics of KDM5B during neuronal differentiation. In line with 
our previous finding, both western blot and RT-qPCR results verified that KDM5B 
expression declined after withdrawal of LIF and neuronal induction with B27 supplement 
(Figure 2.8 A and B). KDM5B expression declined by 20% at differentiation day 5, then 
further 40% at differentiation day 7. However, KDM5A levels remained relatively stable 
until differentiation day 7 and KDM5C showed upregulation from differentiation day 3 
and downregulation at day 7 (Figure 2.8 A). Both Oct4 and Nanog were downregulated 
immediately upon LIF removal (Figure 2.8 A).  
In addition, important neurogenesis marks such as AscI, Nestin, Pax6 and TrkB were 
immediately upregulated after the withdrawal of LIF and neuronal induction with B27 
supplement. Pax6 declined at day 7 and TrkB was downregulated after day 3 (Figure 2.8 
C). Notably, the DNA methyltransferase Dmnt3b, which negatively regulates stem cell 
pluripotency, increased gradually upon LIF removal (Figure 2.8 C).   
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Figure 2.7: KDM5B knockdown in mESCs displayed normal morphology but 
caused compensational upregulation of KDM5C. A) Stable KDM5B knockdown 
mESCs. Whole cell lysate was collected 5 days after viral infection and puromycin 
selection; 5 µg of protein was loaded on each lane. B) KDM5B knockdown mESCs had 
same morphology of control mESCs. Both cells were infected by same MOI of viral 
particles. Images were taken at 100X total magnification with phrase-contrast filter. C) 
KDM5C increased in KDM5B knockdown cells. cDNA samples were prepared on same 
day as whole cell lysates were collected. Sample contained no biological repeats; error-
bar was generated by four technical repeats.  
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Figure 2.8: Downregulation of KDM5B during neuronal differentiation. A) 
Dynamics of KDM5A, KDM5B and KDM5B during neuronal differentiation. Data 
showed here was compared to day 0 (set to 1) in relative expression. Beta-actin and 
ribosomal subunit S18 were the housekeeping genes used for normalization. B) KDM5B 
expression in western blot showed same trend as RT-qPCR. 8% Tris-glycine SDS-PAGE 
in 1X Towbin running buffer was used for protein separation. C) Expression of 
differentiation markers in neurogenesis. Data showed here were relative quantifications 
using same set of housekeeping genes as section A for normalization (IF images of 
differentiated cells showed in (appendix H)).   
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2.2.7 KDM5B knockdown in breast cancer MCF7 cells suppressed cell 
proliferation 
We also conducted siRNA knockdown in MCF7 cells since the lentiviral shRNAs were 
specific to mouse genes only. KDM5B knockdown MCF7 showed lower proliferation 
rate compared to WT. KDM5B overexpression in MCF7 was not detected after 
transfection with a construct that has not been sequenced (Figure 2.9).   
 
 
Figure 2.9: KDM5B knockdown impaired cell proliferation in MCF7 cells. A) Total 
cell counts of MCF7 3 days after transfection. Cell counts were performed using two 
biological repeats and actual counting included four technical repeats. B) KDM5B 
expression significantly decreased after siRNA transfection. 8% Bis-Tris SDS-PAGE in 
1X MOPS running buffer was used for protein separation. C) KDM5B knockdown 
displayed lower culture confluency. Images were taken 3 days after transfection at 100X 
total magnification with phrase-contrast filter. 
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2.2.8 H2BK43me2 was a potential substrate of KDM5B in MCF7 cells but 
not mESCs 
To confirm that H2BK43me2 was a substrate of KDM5B under cell physiological 
conditions, we used both differentiated mESCs and MCF7 cells. In mESCs, KDM5B 
knockdown induced accumulation of H3K4me3 but not H2BK43me2. During 
differentiation, KDM5B was downregulated and H3K4 trimethylation was increased after 
Day 3. No significant upregulation of H2BK43me2 was observed in western blots 
(Figure 2.10 A).  In MCF7 cells, KDM5B knockdown also induced a slight increase of 
H3K4me3. Notably, unlike in mESCs, H2BK43me2 accumulation was observed in 
KDM5B knockdown MCF7 cells (Figure 2.10 B).  
 
Figure 2.10: KDM5B expression affected H3K4me3 and H2BK43me2 levels in 
MCF7 cells. A) KDM5B expression affected H3K4me3 but not H2BK43me2 in mESCs. 
Samples were collected at specific differentiation days and histone methylation was 
protected by adding boiling lysis buffer that contained 2% SDS. 15% Tris-glycine SDS-
PAGE in 1X Towbin running buffer was used for protein separation. B) KDM5B 
expression affected both H3K4me3 and H2BK43me2 in MCF7 cells. Specificity of 
antibodies against histone modification (K4me3 and K43me2) was tested before used in 
western blots (Appendix E). 
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Chapter 3 
General discussion and future study 
3.1 General discussion and conclusions 
Although various studies have been done on KDM5B and its binding partners in recent 
years, the focus remained on histone H3 N-terminal sequences. The recruitment of 
KDM5B by H3K4me3 was unnatural as it binds considerably tight to the PHD3 domain 
(0.5 ± 0.2 M). Nevertheless, all three stages of H3K4, me2, me1 and me0, showed very 
strong binding to PHD3 domain (1.3 ± 0.4 M, 2.0 ± 0.9 M and 4.0 ± 1.7 M 
respectively). Knowing that H3K4me3/2 were substrates of KDM5B, such a tight binding 
may constrain enzymatic reactions. The author reasoned that demethylation mediated by 
KDM5B did not take place at the H3K4me3 it anchored; instead, KDM5B was recruited 
by H3K4me3 and demethylated the surrounding nucleosomes. The hypothetical model 
they suggested did not come with sufficient evidence (Klein et al., 2014). In addition, 
study from Xie et al. suggested that KDM5B could be recruited by H3K36me3 directly. 
In line with this finding, we confirmed that H3K36me3 could be recognized by KDM5B 
in histone excluded cell lysates while it could not be recognized by recombinant KDM5B 
proteins (figure 2.3 and 2.4). This suggests that H3K36me3 might recruit KDM5B 
indirectly in cells. Notably, it was reported that KDM5B did not overlap with H3K36me3 
at the TSS in mESCs ChIP-seq data (Schmitz et al., 2011).  
H2BK43me0 and H2BK43me2 are potential binding partners of KDM5B 
No KDM5B PHD2 binding partner has been identified so far. However, in our histone 
peptide pull-down assay (Figure 2.3), unmodified H2BK43 displayed moderate 
interaction with PHD2; FP analysis have also shown that, though with low affinity, 
unmodified H2BK43 was a potential binding partner to PHD2. Binding between PHD 
domains and methyllysine requires complete coverage of the site with the hydrophobic 
cage of PHD domains. Prolonged binding may constrain potential enzymatic reactions 
taking place on the site. Therefore, having a weak binding between histones and 
chromatin binding proteins is more rational than a nanomolar scale binding which may 
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result in a tight binding and reduce the flexibility of chromatin.  Interestingly, both 
H2BK43 unmodified and H2BK43me2 showed interactions with PHD1, indicating that 
KDM5B was capable of recognizing multiple stages of H2BK43 methylation. It is not 
surprising that H2BK43me2 failed to pull down KDM5B in histone excluded cell lysates. 
Note H2BK43me0 should have been tested instead of H2BK43me2 since it is a better 
binder.  
Like many methyl binding domains, PHD domains of KDM5B has a broad range of 
binding partners (Klein et al., 2014). Most of binding partners of KDM5B, or even the 
whole KDM5 family, is reported to be located on histone H3, which is a core histone that 
has already been well studied. However, the potential binding partners that we identified, 
namely H2B, has not yet been well studied. Elucidating the interactions between 
H2BK43me2 and KDM5B or its other family members can add a further step in the 
understanding of how these demethylases contribute to transcriptional regulations. In our 
study, we showed that H2BK43 and H2BK43me2 peptides could pull down GST-tagged 
PHD1 and PHD2 domains, although interactions were not very strong (Figure 2.3). As 
mentioned above, KDM5 family is not only acting as demethylases but also being 
epigenetic recruiters with their DNA and nucleosome binding domains. It is also possible 
that KDM5B recruits other proteins upon binding to H2BK43me2/0. Our findings were 
mainly based on in vitro experiments, but it is rational that there should be binding 
partners for the PHD2 domains, as all KDM5 members contain this domain. Together, we 
believe that histone H2BK43 and H2BK43me2 are both potential binding partners of 
KDM5B. 
H2BK43 modification can be variant specific 
We successfully confirmed that histone H2BK43me2 exists under cell physiological 
conditions. However, the typical variants, H2B Type2-E that we identified K43me2 on, 
was reported rarely expressing in somatic cells (Molden et al., 2015). Note that Molden 
et al. identified most histone H2B PTMs by lysine propionylation and Arginine-C 
enzyme digestion, we applied a different digestion scheme, and therefore our 
identifications may have shown discrepancy compared to their results. Nevertheless, our 
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western blot results verified the presence of H2BK43me2 in vitro. Knowing the low 
expression of H2B type-E in somatic cells, it is necessary to assess the expression of 
histone H2B variants in mESCs for further understanding. 
H2BK43 is critical for cell survival 
In our histone H2B mutant experiments, only H2BK43 to A was created successfully; 
H2BK43 to R cells were selected out in the mESC medium containing neomycin (Figure 
2.6 B). Since non-viral transfection was achieved by homologous recombination, failure 
to produce H2BK43 to R mutant suggested that this trait was deleterious in natural 
selection. However, compared to H2BK43 to A, we expect a milder phenotype from the 
mimetic mutation to arginine. To fully investigate this phenomenon, lentiviral infection 
of H2BK43 to R and H2BK43 to A could be used. If H2BK43 to R was a true deleterious 
trait, infected cells would not be able to survive in the neomycin selection medium.    
H2BK43me2 is a potential substrate in MCF7 cell 
KDM5B might not be the only enzyme acting on H3K4me3 and H2BK43me2, as 
KDM5C and KDM5A also share the same architecture. Indeed, it was reported that 
KDM5A could also remove methyl groups from H3K4me3/2 (Torres et al., 2015). 
Although most studies focused on the epigenetic reader and DNA binding properties of 
KDM5C (Iwase et al, 2016; Putchkourov et al., 2013), KDM5C was suggested to be a 
H3K4me3 demethylase (Rondinelli et al., 2015). Therefore, the compensatory elevation 
of KDM5C might mask the effect of KDM5B knockdown, and therefore H3K4me3 and 
H2BK43me2 were maintained on stable levels (Figure 2.7 A and Figure 2.8). 
Due to the atypical positioning of H2BK43, identification of H2BK43me2 under cell 
physiological conditions can be elusive. As mentioned above, histone H2B has a 
relatively short N-terminal tail compared to H3 and H4. H2BK43 is covered by DNA 
double helix and therefore its exposure is limited (Figure 1.11). However, different 
conditions such as cell types, cell cycles and extracellular stimulations, may expose this 
site to nucleoplasm by sliding the DNA double helix (Carins, 2007). Therefore, the 
recognition mechanism between H2BK43me2 and KDM5B can also be contingent on the 
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genetic background of cells, which possibly explains why KDM5B knockdowns behaved 
differently in MCF7 than mESCs and differentiated mESCs. In addition, KDM5B shows 
no demethylation activity to H3K4me3 and has no effects on brain development beyond 
E12.5, indicating that cell type is a critical factor to consider when studying epigenetic 
events (Schmitz et al., 2011).   
While our biochemical studies of enzymatic properties of KDM5B have been established, 
investigations in the enzymatic activities under cell physiological conditions are still 
necessary. We observed that accumulation of H3K4me3 occurred after the knockdown of 
KDM5B in both mESCs and MCF7 cells (Figure 2.10). In KDM5B knockdown cells, 
H2BK43me2 levels remained stable in mESCs but increased in MCF7. As mentioned 
earlier, chromatin architectures could be cell type dependent. Without the complete 
profiling of the expression of KDM5 family in MCF7, it is difficult to explain why 
mESCs did not show changes in H2BK43me2 levels. Changes in H3K4me3 levels were 
not only mediated by KDM5B, but other family members as well. The same theory could 
account for H2BK43me2 while it is possible that compensatory effects did not occur in 
MCF7. Note that studies of histone modifications are highly cell status dependent. For 
example, H3S10 phosphorylation only occurs during transcriptional activation of 
immediate-early genes upon mitogen induction (Thomson et al., 2001). However, H3S10 
phosphorylation only occurs spontaneously during G2 phase within pericentromeric 
heterochromatin (Hendzel et al., 1997). During stem cell differentiations, the system 
quickly increases its complexity. Multiple variables are introduced, such as rapid changes 
of chromatin architecture, other competitive nucleosome binding proteins, and dynamics 
of other histone modifications, making the search of right timing that showed maximum 
correlation of KDM5B and H2BK43me2 more difficult and further limited our 
conclusion. Therefore, a fair conclusion to draw at this point is that H2BK43me2 can be a 
potential substrate of KDM5B in MCF7 cells. 
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3.2 Future studies 
To assay whether KDM5B binds to H2BK43me2 under cell physiological conditions, 
demonstration of actual ligand interaction is necessary. One approach is to use fusion 
protein A- mutant BirA (Roux et al., 2012). In brief, cells are first fixed and stained with 
H2BK43me2 specific antibody then biotinylated by protein A- mutant BirA to identify its 
interaction partners. Again, multiple cell lines and different phases of cell cycle need to 
be tested before the best condition is found. This experiment retains a native condition of 
nucleosome and therefore reveals the natural interactions between these proteins. Also, 
comparing the KDM5B ChIP data with H2BK43me2 may help in understanding the 
epigenetic significances behind this interaction.  
To confirm that KDM5B is the enzyme involved in H2BK43me2 demethylation, an 
overexpression of KDM5B can be generated. Unlike the knockdowns in this study, 
overexpression of KDM5B may bypass problems of compensatory effects from other 
KDM5 family members. The KDM5B overexpression construct used in this study was 
not sequenced, which may explain why KDM5B overexpression was not observed. In 
addition, the size of KDM5B is about 160kDa, thus lentiviral infection may have 
provided better results compared to transfection.  
Demethylation and methylation always come in pairs, and therefore it is important to 
study which histone lysine methyltransferase (KMTs) regulates H2BK43 methylations 
after we confirmed that KDM5B catalyzes the demethylations under cell physiological 
conditions. Two possible approaches include using RT-qPCR to screen KMTs that are 
affected in KDM5B knockdown cells and H2BK43me0 peptide pull-down assays. The 
first approach is based on the compensatory effect that may have been caused by 
KDM5B knockdown. Since global histone methylation is likely unchanged, a 
corresponding KMT may need to be downregulated. The second approach relays on a 
potential H2BK43me0 specific KMT that can both read and modify this site. If a specific 
KMT is not directly recruited by H2BK43me0 but it is recruited by other reader proteins, 
then the pull-down assay may not be a suitable method.   
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It is possible that during differentiation, H2BK43me2 level will not show differences in 
global level. However, histone modification can act on specific loci to regulate gene 
expression. In order to explore which genes H2BK43me2 regulates, ChIP-seq analysis 
can be conducted. Based on the histone code theory, it is very likely that H2BK43me2 is 
not acting along but in concert with other histone marks. Therefore, in addition to regular 
ChIP-seq using only H2BK43me2 antibody, Co-ChIP-seq combining other histone 
modification antibodies – such as H3K4me3, H3k9me3 and H3K36me3 – can also be 
used. This approach will not only allow us to elucidate the regulatory regions that 
H2BK43me2 governs, but may also deepen our understanding of how this novel histone 
modification can cross-talk with other known histone marks to regulate gene expression.    
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Tables 
Table 1: List of peptides used in this study 
Name Sequence Special labels 
Histone H3K4me0 Biotin-ahx-MARTK(me0)QTARKS Biotin 
Histone H3K4me1 Biotin-ahx-MARTK(me1)QTARKS Biotin 
Histone H3K4me2 Biotin-ahx-MARTK(me2)QTARKS Biotin 
Histone H3K4me3 Biotin-ahx-MARTK(me3)QTARKS Biotin 
Histone H3K9me0 Biotin-ahx-TKQTARK(me0)STGGKA Biotin 
Histone H3K9me1 Biotin-ahx-TKQTARK(me1)STGGKA Biotin 
Histone H3K9me2 Biotin-ahx-TKQTARK(me2)STGGKA Biotin 
Histone H3K9me3 Biotin-ahx-TKQTARK(me3)STGGKA Biotin 
Histone H3K27me0 Biotin-ahx-ATKAARK(me0)SAPATG Biotin 
Histone H3K27me1 Biotin-ahx-ATKAARK(me1)SAPATG Biotin 
Histone H3K27me2 Biotin-ahx-ATKAARK(me2)SAPATG Biotin 
Histone H3K27me3 Biotin-ahx-ATKAARK(me3)SAPATG Biotin 
Histone H3K36me0 Biotin-ahx-PATGGVK(me0)KPHRYR Biotin 
Histone H3K36me1 Biotin-ahx-PATGGVK(me1)KPHRYR Biotin 
Histone H3K36me2 Biotin-ahx-PATGGVK(me2)KPHRYR Biotin 
Histone H3K36me3 Biotin-ahx-PATGGVK(me3)KPHRYR Biotin 
Histone H3K79me0 Biotin-ahx-EIAQDFK(me0)TDLRFQ Biotin 
Histone H3K79me1 Biotin-ahx-EIAQDFK(me1)TDLRFQ Biotin 
Histone H3K79me2 Biotin-ahx-EIAQDFK(me2)TDLRFQ Biotin 
Histone H3K79me3 Biotin-ahx-EIAQDFK(me3)TDLRFQ Biotin 
Histone H4K20me0 Biotin-ahx-GAKRHRK(me0)VLRDNI Biotin 
Histone H4K20me1 Biotin-ahx-GAKRHRK(me1)VLRDNI Biotin 
Histone H4K20me2 Biotin-ahx-GAKRHRK(me2)VLRDNI Biotin 
Histone H4K20me3 Biotin-ahx-GAKRHRK(me3)VLRDNI Biotin 
Histone H2BK43me0 Biotin-ahx-YVYKVLK(me0)QVHPDT Biotin 
Histone H2BK43me1 Biotin-ahx-YVYKVLK(me1)QVHPDT Biotin 
Histone H2BK43me2 Biotin-ahx-YVYKVLK(me2)QVHPDT Biotin 
Histone H2BK43me3 Biotin-ahx-YVYKVLK(me3)QVHPDT Biotin 
Histone H3K4me0 6FAM-ahx-MARTK(me0)QTARKS Fluorescence 
Histone H3K4me1 6FAM-ahx-MARTK(me1)QTARKS Fluorescence 
Histone H3K4me2 6FAM-ahx-MARTK(me2)QTARKS Fluorescence 
Histone H3K4me3 6FAM-ahx-MARTK(me3)QTARKS Fluorescence 
Histone H2BK43me0 6FAM-ahx-YVYKVLK(me0)QVHPDT Fluorescence 
Histone H2BK43me1 6FAM-ahx-YVYKVLK(me1)QVHPDT Fluorescence 
Histone H2BK43me2 6FAM-ahx-YVYKVLK(me2)QVHPDT Fluorescence 
Histone H2BK43me3 6FAM-ahx-YVYKVLK(me3)QVHPDT Fluorescence 
 
 
Table 2: List of shRNAs and siRNAs used in this study 
Name Sequence/ID Type 
sh-Scramble CCTAAGGTTAAGTCGCCCTCG shRNA 
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KDM5B sh-48 (Mouse) TTCGCTTGTGATGTCGATAAA shRNA 
KDM5B sh-86(Mouse) ATCGCTTGCTGCACCGTTATT shRNA 
KDM5B sh-87(Mouse) TCTACTGATTACGAAGGTATT shRNA 
KDM5B sh-91(Mouse) GCCTACATCATGTGAAAGAAT shRNA 
KDM5B sh-92(Mouse) CCTGAAATTCAGGAGCTTTAT shRNA 
si-Scramble Sigma Universal siRNA control siRNA 
KDM5B-si1(Human) SASI_Hs01_00044944 siRNA 
KDM5B-si2(Human) SASI_Hs01_00044945 siRNA 
 
 
Table 3: List of plasmids used in this study 
Name Expression Purpose 
pLKO.1-Scramble Mammalian KDM5B knockdown control 
pLKO.1-sh48 Mammalian KDM5B knockdown 
pLKO.1-sh86 Mammalian KDM5B knockdown 
pLKO.1-sh87 Mammalian KDM5B knockdown 
pLKO.1-sh91 Mammalian KDM5B knockdown 
pLKO.1-sh92 Mammalian KDM5B knockdown 
pCMV-dR8.2 Mammalian Lentiviral packaging plasmid 
pCMV-VSVG Mammalian Lentiviral envelop plasmid 
pENTR3C-KDM5B Bacterial Donor Plasmid 
pGEX-6P-1-PHD1 Bacterial Protein purification 
pGEX-6P-1-PHD2 Bacterial Protein purification 
pGEX-6P-1-PHD3 Bacterial Protein purification 
pMAX-DEST Mammalian KDM5B overexpression 
pLenti-CMV-Puro-DEST Mammalian KDM5B overexpression 
pEGFP-H2BK43WT-3xFlag Mammalian H2B expression 
pEGFP-H2BK43-A-3xFlag Mammalian H2B mutant expression 
pEGFP-H2BK43-R-3xFlag Mammalian H2B mutant expression 
 
 
 
 
 
 
Table 4: List of primers used in this study 
Plasmid Forward primer Reverse primer 
pGEX-
6P-1 
GGGCTGGCAAGCCACGTTTGGTG  
pCMV CGCAAATGGGCGGTAGGCGTG  
pLKO.1 GACTATCATATGCTTACCGT  
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Gene Forward primer Reverse primer 
Oct4 TAGGTGAGCCGTCTTTCCAC GCTTAGCCAGGTTCGAGGAT 
Sox2 AAGAAAGGAGAGAAGTTTGGAGC
C 
GAGATCTGGCGGAGAATAGTTGG 
Nanog TCTTCCTGGTCCCCACAGTTT GCAAGAATAGTTCTCGGGATGAA 
18S CGGCTACCACATCCAAGGAA GCTGGAATTACCGCGGCT 
GAPDH TCACCACCATGGAGAAGGC GCTAAGCAGTTGGTGGTGCA 
Pax6 TACCAGTGTCTACCAGCCAAT TGCACGAGTATGAGGAGGTCT 
Nestin CCCTGAAGTCGAGGAGCTG CTGCTGCACCTCTAAGCGA 
TrkB CTGGGGCTTATGCCTGCTG AGGCTCAGTACACCAAATCCTA 
GFAP CGGAGACGCATCACCTCTG AGGGAGTGGAGGAGTCATTCG 
Ascl GCAACCGGGTCAAGTTGGT GTCGTTGGAGTAGTTGGGGG 
Actb TCCTAGCACCATGAAGATC AAACGCAGCTCAGTAACAG 
NeuroD1 ACAGACGCTCTGCAAAGGTTT GGACTGGTAGGAGTAGGGATG 
SYP CAGTTCCGGGTGGTCAAGG ACTCTCCGTCTTGTTGGCAC 
Dmnt3B AGCGGGTATGAGGAGTGCAT GGGAGCATCCTTCGTGTCTG 
KDM5B 
(mouse) 
CTGGGAAGAGTTCGCGGAC CGCGGGGTGAAATGAAGTTTAT 
KDM5B 
(human) 
CAATGCTGTGGACCTGTATGT TACGGAGGGTATAGTCCCTGG 
 
Table 5: List of antibodies used in this study 
Target Company Dilution 
KDM5B/JARID1B Abcam 1:5000 
Beta-actin Santa-Cruz 1:2000 
Histone H2B EMD 1:5000 
Histone H3K4me3 Active motif 1:5000 
Histone H3K9me3 Active motif 1:5000 
Histone H2BK43me2 Abcam 1:2000 
Nestin Santa-Cruz 1:100 
GFAP Sigma 1:100 
ND-160 Sigma 1:100 
Beta-III tubulin Santa-Cruz 1: 100 
FLAG Sigma 1:5000 
GST Santa-Cruz 1:2000 
Table 6: Computer-predicted new histone methylation sites 
Prediction ID Name Site Prediction ID Name Site 
0.95 P07305 H1F0 147 0.954 P16403 HIST1H1C 148 
0.948 P07305 H1F0 172 0.95 P16403 HIST1H1C 194 
0.944 P07305 H1F0 193 0.949 P16403 HIST1H1C 183 
0.94 P07305 H1F0 136 0.945 P16403 HIST1H1C 206 
0.937 P07305 H1F0 159 0.944 P16403 HIST1H1C 172 
0.909 P07305 H1F0 122 0.935 P16403 HIST1H1C 137 
0.85 P07305 H1F0 111 0.895 P16403 HIST1H1C 110 
0.932 Q8IZA3 H1FOO 189 0.891 P16403 HIST1H1C 122 
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0.924 Q8IZA3 H1FOO 175 0.858 P16403 HIST1H1C 97 
0.921 Q8IZA3 H1FOO 164 0.848 P16403 HIST1H1C 23 
0.9 Q8IZA3 H1FOO 216 0.942 P16402 HIST1H1D 207 
0.894 Q8IZA3 H1FOO 264 0.94 P16402 HIST1H1D 220 
0.883 Q8IZA3 H1FOO 237 0.938 P16402 HIST1H1D 184 
0.88 Q8IZA3 H1FOO 139 0.931 P16402 HIST1H1D 150 
0.872 Q8IZA3 H1FOO 153 0.927 P16402 HIST1H1D 161 
0.871 Q8IZA3 H1FOO 280 0.919 P16402 HIST1H1D 138 
0.847 Q8IZA3 H1FOO 298 0.91 P16402 HIST1H1D 173 
0.832 Q8IZA3 H1FOO 327 0.899 P16402 HIST1H1D 120 
0.927 Q92522 H1FX 195 0.827 P16402 HIST1H1D 26 
0.912 Q92522 H1FX 166 0.952 P10412 HIST1H1E 130 
0.909 Q92522 H1FX 213 0.95 P10412 HIST1H1E 149 
0.907 Q92522 H1FX 180 0.947 P10412 HIST1H1E 182 
0.875 Q92522 H1FX 146 0.945 P10412 HIST1H1E 197 
0.863 O75367 H2AFY 8 0.944 P10412 HIST1H1E 218 
0.961 P16401 HIST1H1B 150 0.943 P10412 HIST1H1E 169 
0.96 P16401 HIST1H1B 161 0.909 P10412 HIST1H1E 117 
0.956 P16401 HIST1H1B 133 0.871 P10412 HIST1H1E 90 
0.955 P16401 HIST1H1B 207 0.85 P10412 HIST1H1E 34 
0.954 P16401 HIST1H1B 182 0.87 Q96A08 HIST1H2BA 25 
0.951 P16401 HIST1H1B 194 0.845 Q96A08 HIST1H2BA 14 
0.95 P16401 HIST1H1B 220 0.83 Q96A08 HIST1H2BA 36 
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Appendix A. MALDI spectrum example of synthetic histone peptide H2BK43me2. The 
major peak should have mass (m/z) value within 1 Dalton difference compared to 
theoretical mass. Only 0.79 Daltons difference was observed in the spectrum above, 
confirmed the identity of the H2BK43me2 peptide.    
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Appendix B. A) Uncropped WB membrane of KDM5B histone peptide pull-downs. 
KDM5B (red box) is about 180 kDa. B) Double amount of H2BK43me2 beads yielded 
similar pull-down result. Coomassie stained SDS-PAGE showed the amount of 
streptavidin (red box) used in the pull-down. Streptavidin beads were boiled in 100ul of 
1x loading buffer to release any bound proteins. Each lane was loaded with 20ul boiled 
sample. 
 
 
 
Appendix C. Coomassie stained SDS-PAGE of acid extract histones. Approximately 
100ug of histone proteins could be extracted from 1 x 107 cells. Each line was loaded 
with about 2ug of histone extracts. Histone extracts should display very low background 
of non-histone proteins.   
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Appendix D. Sequencing results of histone H2B WT and mutant constructs. Restriction 
sites were highlighted in yellow. 3X FLAG sequences (both DNA and protein) were 
highlighted in green. Specific mutations were highlighted in purple. Note that the cDNA 
sequences were optimized by the supplier to enhance stability and expression efficiency.     
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Appendix E. Example of 1% bleach gel to confirm mRNA integrity. Intact mRNA have 
the 28S band about twice brighter than 18S. Also, no bands/smears were detected below 
18S indicated that degradation did not occur.   
 
 
 
 
 
Appendix F. Validation of antibodies via dot-blot assay. H3K4me3 antibody used in this 
study showed strong cross reaction with H4K20me3. However, considerable molecular 
weight difference between histone H3 and histone H4 allowed us to distinguish them. 
H2BK43me2 antibody showed high specificity in this dot-blot assay. Peptide amount was 
normalized by Ponceau S. staining.  
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Appendix G. Raw data of H2BK43me1/2/3 daughter ions detected by MS in histone 
extracts. From left to right, first five columns indicated positions and detected molecular 
weights of b cleavages (ie: b1 of H2BK43me3 contained only K). b, b-H2O, b-NH3 and b 
(2+) were different status of b ions. For example, b1 ion had same molecular weight 
equals to K; b-H2O ion had molecular weight equals to K minus H2O; b-NH3 ion had 
molecular weight equals to K minus NH3; b (2+) ion had half molecular weight of K. 
Sample principle applied to y ions in the last five columns. Red and blue highlighted 
numbers indicated detections with high confidence. 
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Appendix H. Phase-contrast and confocal microscopy of differentiated mESCs in the 
neurogenesis axis. A) From upper left to lower right were day 3, day 5, day 7 and day 9 
cells in differentiation media. Day 9 picture was taken under 200X total magnifications 
while all other pictures were taken under 100X total magnifications. Neuronal networks 
appeared clearly at Day 9. B) Immunostaining confocal microscopy of Day 12 
differentiated cells. Cells that displayed strong signal of GFAP showed significantly 
weaker signal of ND-160, suggested there was a mixed population in the culture.  
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